Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Stockholders' Equity

v3.23.1
Condensed Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands
Total
Cumulative Effect, Period of Adoption, Adjustment
Common Stock [Member]
Additional Paid-in Capital [Member]
Accumulated Deficit [Member]
Accumulated Deficit [Member]
Cumulative Effect, Period of Adoption, Adjustment
Accumulated Other Comprehensive Loss [Member]
Beginning balance at Dec. 31, 2021 $ 86,500 $ (677) $ 35 $ 431,606 $ (345,037) $ (677) $ (104)
Beginning balance, shares at Dec. 31, 2021     34,972,256        
Common stock issued under employee stock plans, net 570   $ 1 569      
Common stock issued under employee stock plans, net, shares     1,073,543        
Common stock withheld for employee taxes (9,437)     (9,437)      
Common stock withheld for employee taxes, shares     (457,840)        
Common stock issued for acquisition 1,929     1,929      
Common stock issued for acquisition, shares     116,550        
Common stock issued as part of contingent consideration 6,440     6,440      
Common stock issued as part of contingent consideration, shares     352,330        
Stock-based compensation expense 4,847     4,847      
Net loss (22,129)       (22,129)    
Other comprehensive gain (loss) 190           190
Ending balance at Mar. 31, 2022 68,233   $ 36 435,954 (367,843)   86
Ending balance, shares at Mar. 31, 2022     36,056,839        
Beginning balance at Dec. 31, 2021 86,500 $ (677) $ 35 431,606 (345,037) $ (677) (104)
Beginning balance, shares at Dec. 31, 2021     34,972,256        
Net loss 25,557            
Ending balance at Dec. 31, 2022 79,851   $ 36 451,162 (371,271)   (76)
Ending balance, shares at Dec. 31, 2022     36,321,222        
Common stock issued under employee stock plans, net 643   $ 1 642      
Common stock issued under employee stock plans, net, shares     466,906        
Common stock withheld for employee taxes (852)     (852)      
Common stock withheld for employee taxes, shares     (131,116)        
Common stock issued as part of contingent consideration 756     756      
Common stock issued as part of contingent consideration, shares     135,800        
Stock-based compensation expense 4,051     4,051      
Net loss (22,963)       (22,963)    
Other comprehensive gain (loss) (766)           (766)
Ending balance at Mar. 31, 2023 $ 60,720   $ 37 $ 455,759 $ (394,234)   $ (842)
Ending balance, shares at Mar. 31, 2023     36,792,812